Username
 
Password

HyperLink 
 
 
 
 

  Most courses on this
  site require Adobe®
  Reader®
  
CNS
OVERVIEW

This initiative is designed to provide primary care clinicians and sleep specialists with the information they need to assess and effectively treat individuals with narcolepsy and/or excessive daytime sleepiness.

NATIONAL PLANNING COMMITTEE

Ruth M. Benca, MD, PhD
Professor, Departments of Psychiatry and Psychology, and Committee on Neuroscience
Associate Chair, Department of Psychiatry
University of Wisconsin School of Medicine and Public Health
Madison, WI
Consultant Fees: GlaxoSmithKline, sanofi-aventis U.S. LLC, Sepracor Inc., Takeda Pharmaceuticals North America, Inc.
Honoraria: sanofi-aventis U.S. LLC, Sepracor Inc., Takeda Pharmaceuticals North America, Inc.

Paul Doghramji, MD
Assistant Medical Director, Health Services
Ursinus College
Collegeville, PA
Advisory Boards: Cephalon, Inc., sanofi-aventis U.S. LLC, Takeda Pharmaceuticals North America, Inc.
Honoraria: Cephalon, Inc., Pfizer Inc, sanofi-aventis U.S. LLC, Takeda Pharmaceuticals North America, Inc.

Marc L. Gordon, MD
Chief of Neurology, the Zucker Hillside Hospital
Associate Professor of Clinical Neurology, Clinical Psychiatry, and Behavioral Sciences
Department of Neurology
Albert Einstein College of Medicine
New Hyde Park, NY
Consultant Fees: Myriad Genetics, Inc., Teva Pharmaceuticals
Honoraria: EMD Serono/Pfizer, Myriad Genetics, Inc., Novartis Pharmaceuticals Corporation, Ortho-McNeil Neurologics, Inc., Teva Neuroscience,

Joe Lieberman III, MD, MPH
Professor of Family Medicine
Jefferson Medical College
Philadelphia, PA
Consultant Fees: AstraZeneca Pharmaceuticals LP, Pfizer Inc, Takeda Pharmaceuticals North America, Inc.
Honoraria: sanofi-aventis U.S. LLC

Emmanuel Mignot, MD, PhD
Professor of Psychiatry and Behavioral Sciences
Stanford University
Stanford, CA
Consultant Fees: Jazz Pharmaceuticals, Inc.

Thomas Neylan, MD
Associate Professor of Psychiatry
University of California
San Francisco, CA
Consultant Fees: sanofi-aventis U.S. LLC, Sepracor Inc., Takeda Pharmaceuticals North America, Inc.

Peter Aupperle, MD, MPH
Medical Director
The Chatham Institute
Chatham, NJ
No real or apparent conflicts of interest to report

Dan Duch, PhD
Scientific Director
The Chatham Institute
Chatham, NJ
No real or apparent conflicts of interest to report

LEARNING OBJECTIVES

After completing the educational activity, participants should have an increased assessment of the:

DISCLOSURE

It is the policy of The Chatham Institute to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. All faculty, planners, and managers who affect the content of medical education activities sponsored by The Chatham Institute are required to disclose to the audience any real or apparent conflict of interest related to the activity. Faculty, planners, and managers not complying with the disclosure policy will not be permitted to participate in this activity.

SPONSORSHIP AND SUPPORT

This program is sponsored by The Chatham Institute and supported through an educational grant from Jazz Pharmaceuticals.

For additional sleep-related educational activities, please click here